Scotiabank Issues Pessimistic Forecast for Vitalhub (TSE:VHI) Stock Price

Vitalhub (TSE:VHIGet Free Report) had its target price lowered by analysts at Scotiabank from C$15.00 to C$12.00 in a note issued to investors on Wednesday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Scotiabank’s price objective suggests a potential upside of 40.85% from the stock’s previous close.

A number of other equities research analysts have also commented on VHI. Stifel Nicolaus set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research note on Wednesday, October 15th. Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Monday, January 26th. Two analysts have rated the stock with a Strong Buy rating and five have issued a Buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of C$14.33.

View Our Latest Research Report on Vitalhub

Vitalhub Stock Up 3.3%

Shares of VHI stock traded up C$0.27 during trading on Wednesday, reaching C$8.52. The company’s stock had a trading volume of 1,165,726 shares, compared to its average volume of 398,501. The business has a fifty day moving average price of C$9.01 and a 200-day moving average price of C$10.62. Vitalhub has a one year low of C$7.92 and a one year high of C$14.64. The company has a market cap of C$535.31 million, a price-to-earnings ratio of 213.00, a price-to-earnings-growth ratio of 1.18 and a beta of 0.83.

Vitalhub (TSE:VHIGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported C($0.01) EPS for the quarter. The firm had revenue of C$32.04 million during the quarter. Vitalhub had a net margin of 5.11% and a return on equity of 3.01%. Research analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

Insider Transactions at Vitalhub

In related news, Director Anthony Pius Shen purchased 5,470 shares of the company’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was bought at an average price of C$9.23 per share, for a total transaction of C$50,488.10. Following the completion of the transaction, the director owned 5,470 shares in the company, valued at approximately C$50,488.10. The trade was a ∞ increase in their position. Also, Director Francis Nelson Shen acquired 148,700 shares of the company’s stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average cost of C$9.05 per share, with a total value of C$1,345,735.00. Following the completion of the purchase, the director directly owned 148,700 shares of the company’s stock, valued at C$1,345,735. This trade represents a ∞ increase in their ownership of the stock. 18.57% of the stock is owned by company insiders.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

See Also

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.